Letter | Published:

Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons

Abstract

MODERATE non-progressive cognitive impairment is a consistent feature of Duchenne muscular dystrophy (DMD)1,2, although no central nervous system (CNS) abnormality has been identified3. Recent studies have elucidated the molecular defect in DMD, including the absence of the protein dystrophin in affected individuals4. Normal brain tissue contains dystrophin messenger RNA5,6 and dystrophin is present in low abundance in the brain7 and seems to be regulated in this tissue, at least in part, by a promoter that differs from that in muscle8,9. Until now, antibodies and immunocytochemical methods used to demonstrate dystrophin at the plasma membrane of mouse and human muscle have proven inadequate to localize precisely dystrophin in the mammalian CNS. We have now made an antibody (anti 6-10) which is much more sensitive than those previously available to immunolabel dystrophin in the CNS. Using this antibody, we found that in the mouse, dystrophin is particularly abundant in the neurons of the cerebral and cerebellar cortices, and that it is localized at postsynaptic membrane specializations. Dystrophin may have a different role in neurons than in muscle, and an alteration at the synaptic level may be the basis of the cognitive impairment in DMD.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Duchenne, G. B., in De I'Electrisation Localisée et son Application á la Pathologie et á la Therapeutique 3rd edn (Bailliere, Paris, 1872).

  2. 2

    Emery, A. H. in Duchenne Muscular Dystrophy Revised edn, 99–100 (Oxford University Press, New York, 1988).

  3. 3

    Dubowitz, V. & Crome, L. Brain 92, 805–808 (1969).

  4. 4

    Hoffman, E. P. & Kunkel, L. M. Neuron 2, 1019–1029 (1989).

  5. 5

    Nudel, U., Robzyk, K. & Yaffe, D. Nature 331, 635–638 (1988).

  6. 6

    Chamberlain, J. S. et al. Science 239, 1416–1418 (1988).

  7. 7

    Hoffman, E. P., Hudecki, M. S., Rosenberg, P. A., Pollina, C. M. & Kunkel, L. M. Neuron 1, 411–420 (1988).

  8. 8

    Feener, C. A., Koenig, M. & Kunkel, L. M. Nature 338, 509–511 (1989).

  9. 9

    Boyce, F. M., Beggs, A. H., Feener, C. A. & Kunkel, L. M. Proc. natn. Acad. Sci. U.S.A. (in the press).

  10. 10

    Hoffman, E. P., Brown, R. H. & Kunkel, L. P. Cell 51, 919–928 (1987).

  11. 11

    Koenig, M., Monaco, A. P. & Kunkel, L. P. Cell 53, 219–228 (1988).

  12. 12

    Coleman, T. R., Fishkind, D. J., Mooseker, M. S. & Morrow, J. S. Cell Motll Cytoskel. 12, 225–247 (1989).

  13. 13

    Beam, K. G. Nature 333, 798 (1988).

  14. 14

    Chang, H. W., Bock, E. & Bonilla, E. J. biol. Chem. 264, 20831–20834 (1989).

  15. 15

    Bulfield, G., Siller, W. G., Wight, P. A. L. & Moore, K. J. Proc. natn. Acad. Sci. U.S.A. 81, 1189–1192 (1984).

  16. 16

    Marin-Padilla, M. J. comp. Neurol. 167, 63–81 (1985).

  17. 17

    Purpura, D. P. in Brain Mechanisms in Mental Retardation (eds Buchwald, N. A. & Brazer, M. B. D.) 141–169 (Academic, New York, 1985).

  18. 18

    Suetsugu, M. & Mahraein, P. Acta neuropath. 50, 207–210 (1980).

  19. 19

    Takashima, S., Becker, L. E., Armstrong, D. L. & Chan, F. Brain Res. 225, 1–21 (1981).

  20. 20

    Laemmli, U. K. Nature 227, 680–685 (1970).

  21. 21

    Smith, D. B. & Johnson, K. S. Gene 67, 31–40 (1988).

  22. 22

    Byers, T. J., Dubreuil, R., Branton, D., Kiehart, D. P. & Goldstein, L. S. B. J. Cell Biol. 105, 2103–2110.

  23. 23

    Grzanna, R. in Techniques in Immunocytochemistry Vol. 1 (ed. Bullock, G. R. & Petrusz, P.) 183–204 (Academic, New York, 1982).

  24. 24

    Watkins, S. C., Samuel, J. L., Marotte, F., Bertier-Savalle, B. & Rappaport, L. Circulation Res. 60, 327–336 (1987).

  25. 25

    Watkins, S. C., Hoffman, E. P., Slayter, H. S. & Kunkel, L. M. Nature 333, 863–866 (1988).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.